CLINICAL SIGNIFICANCE OF ADIPOSE TISSUE INVASION IN ER-POSITIVE BREAST CANCER

被引:1
|
作者
Liu, Qi [1 ]
Sun, Zheng [1 ]
Li, Long-Long [1 ]
Fu, Zheng-Peng [2 ]
Xu, Chun-Hong [1 ]
机构
[1] Weifang Tradit Chinese Hosp, Dept Breast & Thyroid Surg, Weifang, Shandong, Peoples R China
[2] Weifang Tradit Chinese Hosp, Dept Pathol, Weifang, Shandong, Peoples R China
来源
ACTA MEDICA MEDITERRANEA | 2022年 / 38卷 / 05期
关键词
Adipose tissue invasion; Breast cancer; Molecular subtype; Estrogen receptor; Prognosis;
D O I
10.19193/0393-6384_2022_5_499
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The aim of this study is to investigate the prognostic significance of adipose tissue invasion in breast cancer patients and its potential value for breast cancer therapy. Methods: A total of 162 patients with early breast cancer were selected from June 2014 to June 2015 in Department of Breast and Thyroid Surgery of Weifang Hospital of Traditional Chinese Medicine. The clinical data of the patients were collected, and the relationship between adipose tissue invasion and clinicopathological factors was analyzed. Results: Among the 162 patients, there were 56 cases of breast cancer patients with adipose tissue invasion and 106 cases without adipose tissue invasion. Univariate analysis showed that tumor histological grade (P=0.041), tumor size (P=0.029), lymph node metastasis (P=0.032), positive ER (P=0.001) and molecular subtype (P=0.01) were related to adipose tissue invasion. In addition, Luminal B was positively correlated with the adipose tissue invasion, while TNBC was negatively correlated with the adipose tissue invasion. Logistic regression analysis showed that tumor histological grade (P=0.014), lymph node metastasis (P=0.003), and positive ER (P=0.044) were significantly correlated with adipose tissue invasion. Patients with adipose tissue invasion (24/ 56, 42.85%) had a worse prognosis than those without adipose tissue invasion (26/ 106, 24.58%) at 5-year follow-up (P=0.004). Conclusion: In this study, histological grade, lymph node metastasis and positive ER were found to be associated with adipose tissue invasion of breast cancer, suggesting that adipose tissue invasion is associated with low prognosis of breast cancer and may affect the treatment of ER- positive breast cancer patients.
引用
收藏
页码:3383 / 3387
页数:5
相关论文
共 50 条
  • [1] Frequency and Significance of Basal Phenotype in ER-positive Breast Cancer
    Meyer, Anne-Sophie
    Kriegsmann, Mark
    Waldburger, Nina
    Jung, Audrey
    Behrens, Sabine
    Chang-Claude, Jenny
    Sinn, Hans-Peter
    MODERN PATHOLOGY, 2018, 31 : 91 - 91
  • [2] Frequency and Significance of Basal Phenotype in ER-positive Breast Cancer
    Meyer, Anne-Sophie
    Kriegsmann, Mark
    Waldburger, Nina
    Jung, Audrey
    Behrens, Sabine
    Chang-Claude, Jenny
    Sinn, Hans-Peter
    LABORATORY INVESTIGATION, 2018, 98 : 91 - 91
  • [3] Renalase overexpression in ER-positive breast cancer
    Yu, Xuewen
    Han, Pengxun
    Wang, Jiachuan
    Sun, Huili
    Shao, Mumin
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2018, 11 (03): : 1297 - 1307
  • [4] Late recurrence in ER-positive breast cancer
    Gralow, J.
    CANCER RESEARCH, 2019, 79 (04)
  • [5] Predicting late recurrence in ER-positive breast cancer
    Jack Cuzick
    Nature Reviews Clinical Oncology, 2019, 16 : 406 - 408
  • [6] What is the best therapy for ER-positive breast cancer?
    不详
    EJC SUPPLEMENTS, 2004, 2 (09): : 62 - 64
  • [8] Clinical significance of ESR1 mutations detection both in a snapshot and serially in ER-positive breast cancer patients
    Takeshita, Takashi
    Tomiguchi, Mai
    Sueta, Aiko
    Fujiki, Yoshitaka
    Ibusuki, Mutsuko
    Yamamoto, Yutaka
    Iwase, Hirotaka
    CANCER SCIENCE, 2018, 109 : 522 - 522
  • [9] Heterogeneity and clinical significance of ESR1 mutations in ER-positive metastatic breast cancer patients receiving fulvestrant
    Jill M. Spoerke
    Steven Gendreau
    Kimberly Walter
    Jiaheng Qiu
    Timothy R. Wilson
    Heidi Savage
    Junko Aimi
    Mika K. Derynck
    Meng Chen
    Iris T. Chan
    Lukas C. Amler
    Garret M. Hampton
    Stephen Johnston
    Ian Krop
    Peter Schmid
    Mark R. Lackner
    Nature Communications, 7
  • [10] The role of the AR/ER ratio in ER-positive breast cancer patients
    Rangel, Nelson
    Rondon-Lagos, Milena
    Annaratone, Laura
    Osella-Abate, Simona
    Metovic, Jasna
    Mano, Maria Piera
    Bertero, Luca
    Cassoni, Paola
    Sapino, Anna
    Castellano, Isabella
    ENDOCRINE-RELATED CANCER, 2018, 25 (03) : 163 - 172